Taylor Morrison Home Future Growth
Future criteria checks 1/6
Taylor Morrison Home is forecast to grow earnings and revenue by 10.9% and 4.7% per annum respectively while EPS is expected to grow by 12.2% per annum.
Key information
10.9%
Earnings growth rate
12.2%
EPS growth rate
| Consumer Durables earnings growth | 8.7% |
| Revenue growth rate | 4.7% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 19 Aug 2024 |
Recent future growth updates
Recent updates
What Is Taylor Morrison Home Corporation's (NYSE:TMHC) Share Price Doing?
Jun 28
Is Taylor Morrison Home (NYSE:TMHC) Using Too Much Debt?
Jun 09Taylor Morrison Home Corporation: After Rising Through The Roof, Shares Offer Additional Upside
May 26Taylor Morrison Home Corporation Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
May 03Earnings Working Against Taylor Morrison Home Corporation's (NYSE:TMHC) Share Price
Apr 14Is It Time To Consider Buying Taylor Morrison Home Corporation (NYSE:TMHC)?
Mar 11Taylor Morrison Home: Fairly Priced As Momentum Builds For 2025
Mar 11Taylor Morrison Home Corporation (NYSE:TMHC) Shares Could Be 27% Above Their Intrinsic Value Estimate
Feb 05Taylor Morrison Home Corporation: Cheap With Caveats
Jan 27Is Taylor Morrison Home (NYSE:TMHC) Using Too Much Debt?
Jan 20Lacklustre Performance Is Driving Taylor Morrison Home Corporation's (NYSE:TMHC) Low P/E
Dec 21At US$46.59, Is It Time To Put Taylor Morrison Home Corporation (NYSE:TMHC) On Your Watch List?
Dec 03Taylor Morrison: Reasonable Valuation And Approaching Bottom (Rating Upgrade)
Nov 14These 4 Measures Indicate That Taylor Morrison Home (NYSE:TMHC) Is Using Debt Reasonably Well
Oct 16With EPS Growth And More, Taylor Morrison Home (NYSE:TMHC) Makes An Interesting Case
Sep 16Calculating The Intrinsic Value Of Taylor Morrison Home Corporation (NYSE:TMHC)
Aug 31Taylor Morrison: Comes Down To Supply-Demand
Aug 30Is Taylor Morrison Home Corporation (NYSE:TMHC) Potentially Undervalued?
Aug 01Taylor Morrison Home (NYSE:TMHC) Could Easily Take On More Debt
Jul 04Taylor Morrison Home: Moving To Neutral Post The Recent Run-Up (Rating Downgrade)
Jun 16Is Now The Time To Put Taylor Morrison Home (NYSE:TMHC) On Your Watchlist?
Jun 03Are Taylor Morrison Home Corporation (NYSE:TMHC) Investors Paying Above The Intrinsic Value?
May 18At US$41.90, Is It Time To Put Taylor Morrison Home Corporation (NYSE:TMHC) On Your Watch List?
May 03We Think Taylor Morrison Home (NYSE:TMHC) Can Stay On Top Of Its Debt
Apr 04We Ran A Stock Scan For Earnings Growth And Taylor Morrison Home (NYSE:TMHC) Passed With Ease
Mar 03Estimating The Intrinsic Value Of Taylor Morrison Home Corporation (NYSE:TMHC)
Feb 16Taylor Morrison Home Corporation Q4 2022 Earnings Preview
Feb 14What Is Taylor Morrison Home Corporation's (NYSE:TMHC) Share Price Doing?
Feb 01Taylor Morrison Home Still Makes Sense Despite Pain That Lies Ahead
Jan 17Taylor Morrison Home (NYSE:TMHC) Has A Pretty Healthy Balance Sheet
Dec 29Do Taylor Morrison Home's (NYSE:TMHC) Earnings Warrant Your Attention?
Nov 19News Flash: 8 Analysts Think Taylor Morrison Home Corporation (NYSE:TMHC) Earnings Are Under Threat
Nov 01Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 7,508 | 956 | 387 | N/A | 1 |
| 12/31/2025 | 8,443 | 935 | 759 | 541 | 5 |
| 12/31/2024 | 7,888 | 866 | 689 | 426 | 5 |
| 6/30/2024 | 7,386 | 733 | -195 | -165 | N/A |
| 3/31/2024 | 7,456 | 768 | 299 | 328 | N/A |
| 12/31/2023 | 7,418 | 769 | 773 | 806 | N/A |
| 9/30/2023 | 7,890 | 872 | 1,143 | 1,198 | N/A |
| 6/30/2023 | 8,249 | 1,011 | 1,481 | 1,519 | N/A |
| 3/31/2023 | 8,184 | 1,067 | 1,359 | 1,398 | N/A |
| 12/31/2022 | 8,225 | 1,053 | 1,077 | 1,108 | N/A |
| 9/30/2022 | 8,238 | 1,050 | 912 | 940 | N/A |
| 6/30/2022 | 8,062 | 909 | 656 | 670 | N/A |
| 3/31/2022 | 7,787 | 742 | 560 | 578 | N/A |
| 12/31/2021 | 7,501 | 663 | 355 | 377 | N/A |
| 9/30/2021 | 6,553 | 485 | 194 | 222 | N/A |
| 6/30/2021 | 6,394 | 431 | 661 | 702 | N/A |
| 3/31/2021 | 6,201 | 373 | 867 | 907 | N/A |
| 12/31/2020 | 6,129 | 243 | 1,086 | 1,123 | N/A |
| 9/30/2020 | 6,038 | 204 | 1,001 | 1,038 | N/A |
| 6/30/2020 | 5,444 | 156 | 536 | 571 | N/A |
| 3/31/2020 | 5,183 | 172 | 464 | 494 | N/A |
| 12/31/2019 | 4,762 | 255 | 363 | 393 | N/A |
| 9/30/2019 | 4,753 | 210 | 208 | 233 | N/A |
| 6/30/2019 | 4,685 | 236 | 247 | 271 | N/A |
| 3/31/2019 | 4,400 | 213 | 83 | 107 | N/A |
| 12/31/2018 | 4,227 | 206 | 115 | 136 | N/A |
| 9/30/2018 | 4,069 | 219 | 293 | 309 | N/A |
| 6/30/2018 | 3,941 | 159 | 286 | 297 | N/A |
| 3/31/2018 | 3,869 | 126 | N/A | 239 | N/A |
| 12/31/2017 | 3,885 | 91 | N/A | 386 | N/A |
| 9/30/2017 | 3,783 | 88 | N/A | 363 | N/A |
| 6/30/2017 | 3,728 | 70 | N/A | 407 | N/A |
| 3/31/2017 | 3,674 | 56 | N/A | 537 | N/A |
| 12/31/2016 | 3,550 | 53 | N/A | 373 | N/A |
| 9/30/2016 | 3,323 | 51 | N/A | 151 | N/A |
| 6/30/2016 | 3,266 | 48 | N/A | 96 | N/A |
| 3/31/2016 | 3,113 | 42 | N/A | -109 | N/A |
| 12/31/2015 | 2,977 | 45 | N/A | -263 | N/A |
| 9/30/2015 | 3,018 | 53 | N/A | -34 | N/A |
| 6/30/2015 | 2,851 | 54 | N/A | -76 | N/A |
| 3/31/2015 | 2,747 | 61 | N/A | -57 | N/A |
| 12/31/2014 | 2,708 | 60 | N/A | -134 | N/A |
| 9/30/2014 | 2,088 | 46 | N/A | -185 | N/A |
| 6/30/2014 | 2,093 | 46 | N/A | -208 | N/A |
| 3/31/2014 | 2,005 | 40 | N/A | -345 | N/A |
| 12/31/2013 | 1,916 | 30 | N/A | -152 | N/A |
| 9/30/2013 | 2,082 | 369 | N/A | -394 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TMHC's forecast earnings growth (10.9% per year) is above the savings rate (2.5%).
Earnings vs Market: TMHC's earnings (10.9% per year) are forecast to grow slower than the US market (15.1% per year).
High Growth Earnings: TMHC's earnings are forecast to grow, but not significantly.
Revenue vs Market: TMHC's revenue (4.7% per year) is forecast to grow slower than the US market (8.8% per year).
High Growth Revenue: TMHC's revenue (4.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if TMHC's Return on Equity is forecast to be high in 3 years time